1. Home
  2. CVI vs RCUS Comparison

CVI vs RCUS Comparison

Compare CVI & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVR Energy Inc.

CVI

CVR Energy Inc.

N/A

Current Price

$36.52

Market Cap

3.2B

Sector

Energy

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$29.78

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVI
RCUS
Founded
1906
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
CVI
RCUS
Price
$36.52
$29.78
Analyst Decision
Strong Sell
Buy
Analyst Count
5
10
Target Price
$28.75
$31.90
AVG Volume (30 Days)
921.3K
1.2M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
4.34%
N/A
EPS Growth
350.00
N/A
EPS
N/A
N/A
Revenue
$7,162,000,000.00
$247,000,000.00
Revenue This Year
$2.71
N/A
Revenue Next Year
N/A
$45.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.62
$10.07
52 Week High
$41.67
$31.74

Technical Indicators

Market Signals
Indicator
CVI
RCUS
Relative Strength Index (RSI) N/A 56.03
Support Level N/A $25.94
Resistance Level N/A $31.41
Average True Range (ATR) 0.00 1.14
MACD 0.00 0.12
Stochastic Oscillator 0.00 60.09

Price Performance

Historical Comparison
CVI
RCUS

About CVI CVR Energy Inc.

CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. Subsidiaries include several complex, full-coking crude oil refineries, along with a crude oil gathering system, pipelines, storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: